跳至主要内容
临床试验/NL-OMON52222
NL-OMON52222已完成不适用

Optimal postoperative Pain management After Lung surgery (OPtriAL): multi-centre randomised trial - OPtriA

Maxima Medisch Centrum0 个研究点目标入组 420 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
420

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients referred for anatomical lung resection (pneumonectomy, (bi)lobectomy
  • or segmentectomy) with the intention of performing it by VATS or RATS are
  • eligible for the trial. Adult patients older than 18 years who are able to give
  • informed consent and fill out questionnaires in Dutch.

排除标准

  • Patients with contra-indications for TEA or PVB (infection at skin site,
  • increased intracranial pressure, non-correctable coagulopathy, sepsis and
  • mechanical spine obstruction) or allergic reactions to local anaesthetics will
  • be excluded. Patients chronically using opioids for reasons not related to the
  • operation will be excluded from the study since postoperative baseline opioid
  • requirement will be higher and TEA remains the preferred technique for these
  • patients. If, prior to the procedure, catheter placement during TEA is
  • unsuccessful, a continuous PVB will be given during the procedure, and, if
  • catheter placement during PVB is unsuccessful, a single shot multilevel ICNB
  • will be used. Non-inferiority will be analysed based on intention-to-treat, as
  • well as per-protocol analysis.
  • In case the lung surgeon estimates the operation to be performed through a
  • thoracotomy technique instead of a VATS the patient will be excluded.

研究者

发起方
Maxima Medisch Centrum

相似试验